While venture capital for cultivated meat has cooled and several high-profile players in the space stumbled, the center of gravity for cellular agriculture is shifting away from startup economics and ...
Ozempic maker Novo Nordisk agreed to sell an experimental cell therapy for Parkinson's disease to Cellular Intelligence and take a stake in the U.S. startup, Cellular Intelligence said Monday. Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results